SKI Market

Indian Indices

Nifty

25,509.70 -87.95
(-0.34%)

Sensex

83,311.01 -148.14
( -0.18%)

Bank Nifty

57,554.25 -272.80
( -0.47%)

Nifty IT

35,337.60 63.05
( 0.18%)

Global Indices

Nasdaq

46,931.02 -400.98
(-0.85%)

Dow Jones

6,741.06 -76.23
(-1.12%)

Hang Seng

50,848.14 635.87
(1.27%)

Nikkei 225

9,736.38 -40.70
(-0.42%)

Forex

USD-INR

88.68 -0.07
(-0.08%)

EUR-INR

101.96 -0.30
(-0.29%)

GBP-INR

115.92 -0.66
(-0.56%)

JPY-INR

0.58 0.00
(0.22%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

299.4743419

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

31.18

731.05

EPS(TTM)

Face Value()

Div & Yield %

49.65

0.05

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	348.16	274.68	224.46	133.89	112.77	97.02
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	348.16	274.68	224.46	133.89	112.77	97.02
Other Income	0.92	1.82	1.63	1.40	0.52	0.38
Stock Adjustments	22.44	37.72	0.01	-1.17	5.04	6.08
Total Income	371.52	314.22	226.10	134.12	118.33	103.48
EXPENDITURE :
Raw Materials	282.42	245.57	176.45	100.60	86.12	65.96
Power & Fuel Cost	4.03	3.17	3.68	3.32	3.21	3.10
Employee Cost	12.50	11.54	10.66	8.66	8.95	8.04
Other Manufacturing Expenses	11.68	8.08	6.59	3.87	4.41	3.03
Selling & Administrative Expenses	20.77	14.55	12.76	7.80	6.43	9.83
Miscellaneous Expenses	1.22	1.71	0.46	0.28	0.37	2.90
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	332.61	284.62	210.60	124.54	109.48	92.87
Operating Profit	38.90	29.60	15.50	9.58	8.85	10.62
Interest	13.65	9.28	4.74	4.37	4.48	3.13
Gross Profit	25.25	20.32	10.76	5.21	4.37	7.49
Depreciation	3.80	2.81	2.16	2.00	1.88	1.33
Profit Before Tax	21.45	17.51	8.60	3.21	2.49	6.16
Tax	5.54	4.29	2.21	0.76	0.44	1.72
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.29	2.41	0.05	0.44	0.15	-0.02
Reported Net Profit	15.62	10.81	6.34	2.01	1.90	4.46
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	15.62	10.81	6.34	2.01	1.90	4.46
Adjustment below Net Profit	-0.07	0.05	0.02	0.00	8.27	0.00
P & L Balance brought forward	28.55	18.00	11.93	10.18	0.00	3.70
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.33	0.31	0.28	0.27	0.00	0.31
P & L Balance carried down	43.77	28.55	18.00	11.93	10.18	7.84
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	7.00	7.00	7.00	7.00	6.60	6.50
Dividend Per Share(Rs)	0.70	0.70	0.70	0.70	0.66	0.65
Earnings Per Share-Unit Curr	33.25	23.84	14.29	5.05	4.77	11.18
Earnings Per Share(Adj)-Unit Curr	33.25	23.84	14.29	5.05	4.77	11.18
Book Value-Unit Curr	255.15	194.27	153.07	107.96	103.57	97.73
Book Value(Adj)-Unit Curr	255.15	194.27	153.07	107.96	103.57	97.73

25,509.70 -87.95 (-0.34%)

83,311.01 -148.14 ( -0.18%)

57,554.25 -272.80 ( -0.47%)

35,337.60 63.05 ( 0.18%)

46,931.02 -400.98 (-0.85%)

6,741.06 -76.23 (-1.12%)

50,848.14 635.87 (1.27%)

9,736.38 -40.70 (-0.42%)

88.68 -0.07 (-0.08%)

101.96 -0.30 (-0.29%)

115.92 -0.66 (-0.56%)

0.58 0.00 (0.22%)